Bio-Gate AG Completes Capital Increase and Rights Offering

On August 18, 2026, Bio-Gate AG, based in Nuremberg, announced the completion of a capital increase through authorized capital and a rights offering, as approved in the Annual General Meeting on June 30, 2026. This financial move resulted in 415,000 new shares being issued at 2.80 euros each, generating gross proceeds of 1,162,000 euros.

The share capital of the company increased from 2,038,738 euros to 2,453,738 euros. The executive board, with the supervisory board's consent, decided to raise the share capital by issuing 171,429 new shares through a private placement, excluding existing shareholders' subscription rights. This step generated 480,001.20 euros for immediate investments.

Additionally, the rights offering involved 243,571 new shares, contributing 681,998.80 euros towards strengthening equity and enhancing financial flexibility for future investments.